New Researches In Treatment Of Rheumatoid Arthritis

New Researches In Treatment Of Rheumatoid Arthritis.

About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a untrodden enquiry finds June 2013. Rheumatoid arthritis affects about one in 100 proletariat worldwide and can cause gradual joint destruction, deformity, pain and stiffness. The disease can reduce real function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs fallen their effectiveness, the study authors found viagra. Other reasons included security concerns (20 percent), doctor preference (nearly 28 percent), accommodating preference (about 18 percent) and access to treatment (9 percent), according to the den results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.

Rheumatoid arthritis "is a growing disease, which, if left untreated, can significantly and non-stop reduce joint function, patient mobility and quality of life," study lead founder Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR communication release "Studies have shown that patients sustain maximum benefit from rheumatoid arthritis healing in the first two years - yet our data highlight significant discontinuation rates during this set period".

The study included more than 6200 rheumatoid arthritis patients who started treatment by taking either tumor necrosis influence inhibitors (TNFi) or non-TNFi biologics. In the TNFi group, the percentages of patients who continued taking their medications were about 82 percent at six months, 68 percent at 12 months and 52 percent at 24 months.

In the non-TNFi group, the percentages for those corresponding regulate periods were about 81 percent, 63 percent and 46 percent, respectively. The customary ease to medication discontinuation was 26,5 months in the TNFi faction and 20,5 months in the non-TNFi group, the investigators found.

"While there is no pickle for rheumatoid arthritis, initiating treatment early and improving adherence can depute patients to lead active and productive lives," Strand said in the story release breast. The data and conclusions of research presented at medical meetings should be viewed as preparation until published in a peer-reviewed journal.

tag : percent arthritis rheumatoid patients months treatment study group medications

Post a comment

Private comment



Welcome to FC2!

Latest journals
Latest comments
Latest trackbacks
Monthly archive
Search form
Display RSS link.
Friend request form

Want to be friends with this user.